Carglumic acid (Carbaglu®) treatment in hyperammonemia post liver transplantation
Endocrinol Diabetes Nutr (Engl Ed). 2020 Feb;67(2):148-149.
doi: 10.1016/j.endinu.2019.06.006.
Epub 2019 Aug 22.
[Article in
English,
Spanish]
Affiliations
- 1 Centro de Investigación Biomédica en Red-Fisiopatología de Obesidad y Nutrición, (CIBERobn), Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Spain; Department of Endocrinology & Nutrition and Metabolic Unit Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: francisco.arrieta@salud.madrid.org.
- 2 Department of Pediatrics, Nutrition and Metabolic Unit, Hospital Universitario Ramón y Cajal, Madrid, Spain.
- 3 Department of Anesthesia and Reanimation, University Hospital Ramón y Cajal, Spain.
- 4 Gastroenterology Department, Hospital Universitario Ramón y Cajal, Spain.
- 5 Pharmacy Department, University Hospital Ramón y Cajal, Madrid, Spain.
No abstract available
MeSH terms
-
Glutamates / therapeutic use*
-
Humans
-
Hyperammonemia / drug therapy*
-
Liver Transplantation*
-
Male
-
Middle Aged
-
Postoperative Complications / drug therapy*
Substances
-
Glutamates
-
carglumic acid